Indications & Dose:
Induction of anaesthesia using 0.5%or 1%injection
Adult 18–54 years: Usual dose 1.5–2.5 mg/kg, to be administered at a rate of 20–40 mg every 10 seconds until response, for debilitated patients use dose for 55 years and over
Adult 55 years and over: Usual dose 1–1.5 mg/kg, to be administered at a rate of 20 mg every 10 seconds until response
Induction of anaesthesia using 2%injection
Adult 18–54 years: Usual dose 1.5–2.5 mg/kg, to be administered at a rate of 20–40 mg every 10 seconds until response. For debilitated patients use dose for 55 years and over
Adult 55 years and over: Usual dose 1–1.5 mg/kg, to be administered at a rate of 20 mg every 10 seconds until response
Maintenance of anaesthesia using 1%injection
Adult: Usual dose 4–12 mg/kg/hour, alternatively (by slow intravenous injection) 25–50 mg, dose may be repeated according to response, for debilitated patients use dose for elderly
Elderly: Usual dose 3–6 mg/kg/hour, alternatively (by slow intravenous injection) 25–50 mg, dose may be repeated according to response
Maintenance of anaesthesia using 2%injection
Adult: Usual dose 4–12 mg/kg/hour, for debilitated patients use dose for elderly
Elderly: Usual dose 3–6 mg/kg/hour
Sedation of ventilated patients in intensive care using 1%or 2%injection
Adult: Usual dose 0.3–4 mg/kg/hour, adjusted according to response
Induction of sedation for surgical and diagnostic
procedures using 0.5%or 1%injection
Adult: Initially 0.5–1 mg/kg, to be administered over 1–5 minutes, dose and rate of administration adjusted according to desired level of sedation and response
Maintenance of sedation for surgical and diagnostic procedures using 0.5%injection
Adult: Initially 1.5–4.5 mg/kg/hour, dose and rate of administration adjusted according to desired level of sedation and response, followed by continued (by slow intravenous injection) 10–20 mg, (if rapid increase in sedation required), patients over 55 years or debilitated may require lower initial dose and rate of administration
Maintenance of sedation for surgical and diagnostic procedures using 1%injection
Adult: Initially 1.5–4.5 mg/kg/hour, dose and rate of administration adjusted according to desired level of sedation and response, followed by (by slow intravenous injection) 10–20 mg, (if rapid increase in sedation required), patients over 55 years or debilitated may require lower initial dose and rate of administration
Maintenance of sedation for surgical and diagnostic procedures using 2%injection
Adult: Initially 1.5–4.5 mg/kg/hour, dose and rate of administration adjusted according to desired level of sedation and response, followed by (by slow intravenous injection) 10–20 mg, using 0.5%or 1% injection (if rapid increase in sedation required), patients over 55 years or debilitated may require lower initial dose and rate of administration
Contraindications:
If history of propofol allergy, bacterial contamination.
ABSOLUTE CONTRA INDICATION: Airway obstruction
Side Effects:
CVS depression, respiratory depression, excitatory Phenomena, pain at injection site, allergic reaction, post-operative nausea/vomiting, tremor, hiccup, ophthalmoplegia, rash, anaphylaxis.
Cautions:
Monitor blood lipid concentrations in patients at risk of fat overload.
Precautions:
Interaction:
DRUGS
CNS depressants: Additive CNS depressant, respiratory depressant, and hypotensive effects; possibly decreased emetic effects of opioids droperidol: Possibly decreased control of nausea and vomiting ACTIVITIES
alcohol use: Additive CNS depressant, respi-ratory depressant, and hypotensive effects
Warnings:
Adverse Effects:
Lactations:
Special Precautions:
Hypovolaemia, epilepsy, dyslipidaemia, increased intracranial pressure, ECT, concurrent medication.
Pregnancy: Use only if clearly indicated. Not recommended for delivery or caesarian section.
Breast-feeding: Not recommended.
Old age: Reduced dose as per body wt.
BACTERIAL CONTAMINATION. In order to eliminate the risk of infection from bacterial contamination strict aseptic technique must be used when drawing-up propofol emulsion
Counselling:
Side Effects Or Adverse Reactions:
CV: Bradycardia, hypotension
GI: Nausea, vomiting
MS: Involuntary muscle movement (transient)
RESP: Apnea
Other: Anaphylaxis, injection-site burning, pain, or stinging
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team